Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oozfix (carboxymethyl starch) for prevention of postoperative complications after gastrectomy
KCT0007511Phase 4Not yet recruiting
- Sponsor
- Hanmi Healthcare
- Start
- Jul 2022
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of OOZFIX in gastric cancer (GC), sponsored by Hanmi Healthcare. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
OOZFIX
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0007511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007511.